The choice affects who controls the design, who carries the IP, how much engineering work falls on your team, and how fast you reach a usable first article. Get it wrong and you end up with change orders, inspection disputes, or a supplier guessing at tolerances that were never fully defined.
Neither model wins by default. The right answer depends on how mature your design is, how much engineering capacity you have in-house, your production volume, and how much manufacturing input you actually want. This article breaks down both models so you can pick the one that fits your program.
Key Takeaways
- Build-to-print manufactures to customer-controlled drawings, CAD, materials, tolerances, and inspection requirements.
- Design and spec (build-to-spec) shifts more responsibility to the manufacturer to turn performance requirements into a producible design.
- Mature, validated proprietary designs fit build-to-print and tighter configuration control.
- Choose design-and-spec when internal engineering capacity is limited or the design is still evolving.
- A hybrid approach often works best: DFM input during development, then build-to-print once the design locks.
Build to Print Manufacturing vs Design and Spec: Quick Comparison
The two models split engineering responsibility differently at nearly every stage of a program. This table compares them on the points that usually drive orthopedic component sourcing decisions:
| Factor | Build-to-Print | Design-and-Spec |
|---|---|---|
| Design authority | OEM retains authority over geometry, dimensions, materials, tolerances, and revisions | Manufacturer takes greater responsibility for developing the design, subject to OEM approval |
| IP and configuration control | Customer-owned drawings and validated configurations support stronger control over proprietary designs | IP ownership, design reuse, and change rights must be defined contractually before work starts |
| Engineering involvement | Manufacturer focuses on process planning, machining strategy, and inspection, not design changes | Manufacturer contributes engineering expertise to solve functional requirements and improve manufacturability |
| Cost and predictability | A complete, mature print makes quoting and planning more predictable; incomplete documentation causes delays | Added engineering work raises upfront effort but can cut downstream machining complexity and waste |
| Best fit | Qualified implant or instrument designs needing controlled, repeatable production | Early-stage or evolving designs where supplier input speeds manufacturability |
Use build-to-print when the implant or instrument design is qualified and you need locked configuration control. Use design-and-spec when early supplier input will improve manufacturability before the design freezes.
What is Build to Print Manufacturing?
Build-to-print means a manufacturer produces a component or assembly exactly to complete customer-provided engineering documentation. According to Applied Engineering's fabrication guide, the customer supplies the drawings, specifications, and material data, and the manufacturer builds to that package without changing the design.
This is not the same thing as 3D printing. Build-to-print describes who controls the design documentation, not how the part is physically made. A build-to-print job might be milled, turned, wire EDM'd, or additively manufactured, depending on what the print calls for.
A complete build-to-print package typically includes:
- Controlled drawings or CAD models
- Material and heat-treatment requirements
- Dimensional tolerances and surface finishes
- Critical-to-function characteristics and inspection criteria
- Packaging requirements and revision status
Division of Responsibility and Handling Gaps
The OEM owns design performance and configuration decisions. The manufacturer owns production execution, process control, inspection, and reporting against the approved requirements.
Tolerance call-outs and datum references on the print establish exactly how a part gets checked. Croom Medical notes that feature-control frames and GD&T give both parties a shared basis for judging whether a component meets its specified geometry.
If a drawing is ambiguous, incomplete, or seemingly impractical to machine as written, a disciplined manufacturer doesn't just make a judgment call. It raises a formal question, documents the concern, and waits for customer approval before touching anything design-related.
Where Build-to-Print Fits Best
This model supports repeat production once a design is finalized:
- First articles built from completed, released drawings
- Repeat purchase orders for validated spinal, joint, trauma, or extremity components
- Revision-controlled replacement parts
- Transferring production from an internal line or a former supplier
It also works for low-volume and developmental programs. The same documentation discipline applies whether the order is a single first article or a full production run—MoManTech covers lot sizes from 1–10 prototype units through 100+ unit orders.
What is Design and Spec Manufacturing?
Design and spec flips the starting point. Instead of handing over a finished drawing, the OEM supplies functional, performance, clinical, dimensional, or regulatory requirements, and the manufacturer helps develop the design and production solution.
The distinction comes down to this: build-to-print answers "how will this exact part be made?" Design and spec answers "what must this part do, and how should it be designed to do it?" Either way, the contract needs to spell out who holds final design approval. That detail doesn't resolve itself.
What Manufacturers Can Contribute
A capable partner working under a design-and-spec arrangement typically offers:
- Material and process recommendations
- Tolerance analysis and machining strategy
- Design-for-manufacturability (DFM) review
- Prototyping and fixture planning
- Inspection planning and production refinement
MoManTech's Design for Manufacturability Consultation works in this space by reviewing precision-machined component designs during the planning stage and applying lean manufacturing practices before a single chip gets cut.
For pre-revenue and small-to-mid-size orthopedic OEMs that don't have a full manufacturing engineering team on staff, this kind of input fills a real gap without requiring them to build every capability internally.
Governance Still Matters
Collaboration doesn't mean the OEM gives up control. Before work begins, the agreement should define:
- Who holds design authority and final sign-off
- IP ownership and design reuse rights
- Validation and verification responsibilities
- Change-control procedures for any design revision
- Who owns design-related regulatory risk
This model fits early-stage spinal, trauma, joint, or extremity programs where the performance target is clear but the drawings, tolerances, and processes are still being worked out.
Supplier DFM input at this stage can flag difficult-to-machine features, unnecessarily tight tolerances, tool-access problems, or inspection challenges before they become production headaches. Done well, it also supports a clean transition from prototype quantities into repeat production without losing traceability on approved changes.
Build to Print vs Design and Spec: What is Better?
Neither model is universally superior. The real question is: how mature is the design, and how much engineering responsibility do you want the manufacturer to carry?
Choose build-to-print when:
- The design is complete, validated, and under configuration control
- You need to retain design and IP authority
- Production requires repeatable output of an already-approved configuration
- Your internal team can resolve design questions without supplier input
Choose design and spec when:
- You need manufacturing-driven input to finish the design
- Documentation is incomplete or still evolving
- You're optimizing for performance, manufacturability, or cost before locking the design
- Internal production-engineering resources are limited
Weigh the decision against these factors:
- Design maturity and configuration control
- Regulatory and validation status
- IP sensitivity
- Expected volumes and prototype needs
- First-article timing
- Tolerance complexity and inspection requirements
- Appetite for mid-program design changes
The Hybrid Path
Many orthopedic programs don't fit neatly into either model. A hybrid path pulls in DFM feedback during development, documents every approved change under formal revision control, then shifts to strict build-to-print once the design and process are stable enough to lock.
That is a natural fit for MoManTech. DFM support, precision CNC and Swiss machining, wire EDM, and an ISO 13485:2016-certified quality system stay consistent whether an OEM arrives with a locked print or a performance spec that still needs engineering work—from first article through full production.
Real-World Examples
Build-to-print in production: MoManTech's automated loading system (nicknamed "BOB") loads high-volume parts onto a Haas mill for lights-out manufacturing. Once a design is locked, that cadence increases capacity and cuts lead time and cost on repeat runs.
Design-and-spec context: The orthopedic industry offers a clear external reference. ZEISS's customer story on Orchid Orthopedic Solutions covers inspection automation on knee femoral components and stemmed tibial plates.
Checking 40 parts fell from roughly three hours to 45–60 minutes, and the process checked more features than before. That supplier-side inspection and documentation gain pays off under either engagement model.
Situational takeaway:
- Mature, controlled designs favor build-to-print
- Evolving designs benefit from supplier DFM input and design-and-spec collaboration
If you have drawings, CAD, performance requirements, or an early component concept, MoManTech can walk through manufacturability, prototyping, first articles, and production planning with your team.
Conclusion
Build-to-print is usually the stronger fit once a design is mature, validated, and under tight configuration control. Design and spec earns its place when a manufacturer's engineering input can genuinely improve the solution — whether that's refining tolerances, reducing material waste, or simplifying a difficult feature.
Either way, clarify responsibility up front, protect your configuration control, and pick a partner with the quality systems to back it up. Bringing manufacturing expertise in early is almost always cheaper than fixing a production problem after the fact.
Frequently Asked Questions
What does "build to print" mean?
Build-to-print means manufacturing a component from complete, customer-supplied drawings and specifications. The term describes who controls the design documentation, not the production method, and is unrelated to 3D printing.
What is the difference between build-to-spec (BTS) and build-to-print (BTP)?
BTP follows a complete, customer-finalized design with no manufacturer input on geometry or tolerances. BTS gives the manufacturer more responsibility for developing a design solution that meets the OEM's stated functional requirements.
What is the design process for manufacturing?
The process includes requirements definition, concept development, DFM review, prototyping, validation, documentation, and a controlled release into production. Each stage builds toward a design that's both functional and producible.
What is DFM (design for manufacturability) in manufacturing?
DFM evaluates whether a design can be produced consistently, efficiently, and at the required quality level before production begins. It often catches tolerance, material, or tooling issues early, before they become costly changes.
What are the main types of manufacturing processes?
The main categories include subtractive machining, forming, casting, additive manufacturing, joining, and finishing. Which one applies depends on the material, part geometry, production volume, and performance requirements.
Is printing considered manufacturing?
Printing can refer to additive manufacturing, where material is built up layer by layer. Build-to-print is a separate concept: manufacturing from customer-provided documentation, regardless of the production method used.
